Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants

American Journal of Transplantation

Volumn 12, Issue 5, 2012, Pages 1133-1145

  Scandling, J D ^a   Busque, S ^a   Dejbakhsh Jones, S ^a   Benike, C ^a   Sarwal, M ^a   Millan, M T ^a,b   Shizuru, J A ^a   Lowsky, R ^a   Engleman, E G ^a   Strober, S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b StemCells Inc   (United States)

Author keywords

Bone marrow transplantation; kidney transplantation

Indexed keywords

ALLOANTIGEN; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BLOOD CELL; CD34 SELECTION; CD4+ CD25+ T LYMPHOCYTE; CELL TRANSPLANTATION; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPH NODE IRRADIATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; STEM CELL;

ADULT; ANTILYMPHOCYTE SERUM; BLOOD GROUP INCOMPATIBILITY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; TRANSPLANTATION CHIMERA; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860433872     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.03992.x     Document Type: Article

References (28)

1. Srinivas TR, Schold JD, Guerra, G, Eagan, A, Bucci CM, Meier-Kriesche HU,. Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Am J Transplant 2007; 7: 586-594.
2. Srinivas TR, Meier-Kriesche HU,. Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result. Clin J Am Soc Nephrol 2008; 3 (Suppl 2): S101-S116.
3. Pascual, M, Theruvath, T, Kawai, T, Tolkoff-Rubin, N, Cosimi AB,. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590.
4. Yang, H,. Maintenance immunosuppression regimens: Conversion, minimization, withdrawal, and avoidance. Am J Kidney Dis 2006; 47 (4 Suppl 2): S37-S51.
5. Cecka JM,. The UNOS Scientific Renal Transplant Registry: 10 years of kidney transplants. Clin Transpl 1997: 1-14.
6. Billingham RE, Brent, L., Medawar PB,. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603-606.
7. Slavin, S, Strober, S, Fuks, Z, Kaplan HS,. Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science 1976; 193: 1252-1254.
8. Slavin, S, Strober, S, Fuks, Z, Kaplan HS,. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 1977; 146: 34-48.
9. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany, D., Sachs DH,. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2-B10). J Immunol 1986; 136: 28-33.
10. Sharabi, Y, Sachs DH,. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493-502.
11. Tomita, Y, Khan, A, Sykes, M,. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994; 153: 1087-1098.
12. Higuchi, M, Zeng, D, Shizuru, J, et al,. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol 2002; 169: 5564-5570.
13. Strober, S, Modry DL, Hoppe RT, et al,. Induction of specific unresponsiveness to heart allografts in mongrel dogs treated with total lymphoid irradiation and antithymocyte globulin. J Immunol 1984; 132: 1013-1018.
14. Huang CA, Fuchimoto, Y, Scheier-Dolberg, R, Murphy MC, Neville DM, Jr., Sachs DH,. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 2000; 105: 173-181.
15. Kawai, T., Cosimi AB, Colvin RB, et al,. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256-262.
16. Millan MT, Shizuru JA, Hoffmann, P, et al,. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 2002; 73: 1386-1391.
17. Fudaba, Y, Spitzer TR, Shaffer, J, et al,. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses. Am J Transplant 2006; 6: 2121-2133.
18. Kawai, T., Cosimi AB, Spitzer TR, et al,. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361.
19. Scandling JD, Busque, S, Dejbakhsh-Jones, S, et al,. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358: 362-368.
20. Lowsky, R, Takahashi, T, Liu YP, et al,. Protective conditioning for acute graft-versus-host disease. N Engl J Med 2005; 353: 1321-1331.
21. Kohrt HE, Turnbull BB, Heydari, K, et al,. TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood 2009; 114: 1099-1109.
22. Scandling JD, Busque, S, Shizuru JA, Engleman EG, Strober, S,. Complete withdrawal of immunosuppressive drugs without rejection after kidney and hematopoietic cell transplantation. N Engl J Med 2011; 365: 1359-1360.
23. Takahashi, T, Dejbakhsh-Jones, S, Strober, S,. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 2006; 176: 211-216.
24. Mehta-Damani, A, Markowicz, S, Engleman EG,. Generation of antigen-specific CD8+ CTLs from naive precursors. J Immunol 1994; 153: 996-1003.
25. Lan, F, Zeng, D, Huie, P, Higgins JP, Strober, S,. Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells express both CD8 and T-cell antigen receptor-alphabeta. Blood 2001; 97: 3458-3465.
26. Baron, F, Baker JE, Storb, R, et al,. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 2004; 104: 2254-2262.
27. Nador RG, Hongo, D, Baker, J, Yao, Z, Strober, S,. The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning. Am J Transplant 2010; 10: 262-272.
28. Hongo D, Tang X, Dutt S, Nador RG, Strober S,. Interactions between NKT Cells and Tregs are required for tolerance to combined bone marrow and organ transplants. Blood 2012; 119: 1581-1589.